NeoGenomics Laboratories, Inc. vs RadNet, Inc.
NeoGenomics Laboratories, Inc. (NEO) and RadNet, Inc. (RDNT) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $1.92B
- Last close
- $14.82
- 12 months
- +39.8%
- Market value
- $5.49B
- Last close
- $69.71
- 12 months
- −12.1%
At a glance
- The biggest part of NeoGenomics Laboratories, Inc.'s revenue is Client direct billing (71%); at RadNet, Inc. it is Commercial insurance (55%).
- By market value, RadNet, Inc. ($5.5B) is about 2.9 times NeoGenomics Laboratories, Inc. ($1.9B).
- Over the last 12 months NeoGenomics Laboratories, Inc.'s share price moved +39.8% and RadNet, Inc.'s −12.1%; against the S&P 500 that is +34.1 points and −17.8 points.
- In their last fiscal years NeoGenomics Laboratories, Inc. kept -14.9% of revenue as net income and RadNet, Inc. -0.9%.
- In the last 90 days insiders reported 0 open-market purchases at NeoGenomics Laboratories, Inc. and 0 at RadNet, Inc.; members of Congress disclosed 1 trade in NeoGenomics Laboratories, Inc. and 0 in RadNet, Inc..
- Next results: NeoGenomics Laboratories, Inc. Feb 15, 2027, RadNet, Inc. Mar 1, 2027.
How each one makes money: NeoGenomics Laboratories, Inc. revenue · RadNet, Inc. revenue
Share prices on one chart
NeoGenomics Laboratories, Inc. and RadNet, Inc., and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| NeoGenomics Laboratories, Inc. NEONASDAQ · Health Care Services | RadNet, Inc. RDNTNASDAQ · Health Care Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $1.92B | $5.49B |
| Revenue, last fiscal year | $727M | $2.04B |
| Net income, last fiscal year | −$108M | −$18.7M |
| Net marginNet income as a share of revenue | -14.9% | -0.9% |
| Free cash flow | −$21.8M | $299M |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is NeoGenomics Laboratories, Inc. different from RadNet, Inc.?
NeoGenomics Laboratories, Inc. (NEO) is in Health Care Services on NASDAQ, with $727M of revenue in its last fiscal year and a net margin of -14.9%. RadNet, Inc. (RDNT) is in Health Care Services on NASDAQ, with $2.04B of revenue in its last fiscal year and a net margin of -0.9%. The biggest part of NeoGenomics Laboratories, Inc.'s revenue is Client direct billing (71%); at RadNet, Inc. it is Commercial insurance (55%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do NeoGenomics Laboratories, Inc. and RadNet, Inc. compare in size?
RadNet, Inc. has the larger market value: NeoGenomics Laboratories, Inc. $1.92B and RadNet, Inc. $5.49B, at the last close.
Whose share price rose more over the last 12 months, NEO or RDNT?
Over the last 12 months NeoGenomics Laboratories, Inc. moved +39.8% and RadNet, Inc. −12.1%. Past price moves say nothing about the future.
Which has had more insider buying, NeoGenomics Laboratories, Inc. or RadNet, Inc.?
Since 2006, NeoGenomics Laboratories, Inc. insiders reported 38 open-market purchases against 7 for RadNet, Inc.. These are counts of what was filed, not a view on either stock.
Do members of Congress trade NEO or RDNT?
In the last 12 months, members of Congress disclosed 1 trades in NeoGenomics Laboratories, Inc. (NEO) and 0 in RadNet, Inc. (RDNT).
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
NeoGenomics Laboratories, Inc. pageRadNet, Inc. pageRare insider trades this weekAll comparisons
https://oqro.io/compare/neo-vs-rdnt
